GRDLY yields 3.69% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, GRDLY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GRDLY + PFE for your $10,000?
Grindrod Limited, together with its subsidiaries, engages in the logistics and financial services business in North America, Bermuda, South America, the Middle East, the United Kingdom, Isle of Man, rest of Europe, Singapore, Asia, the Far East, Australia, South Africa, and Rest of Africa. The company operates through Ports and Terminals, Logistics, Bank, Private Equity and Property, and Marine Fuels and Agricultural Logistics segments. It engages in the bulk terminal activities include receiving, stockpiling, and loading of cargo onto vessels for onward transportation; container handling, transport, warehousing, loading, and offloading; selling and leasing containers; and logistics solutions for the transportation of cargo through road, rail, and sea. The company also provides clearing and forwarding of imports and exports, transportation of goods, and ship husbandry services; and various ancillary services, including training, bay stevedoring, and rentals. In addition, it involves managing and handling port activities; freight services, such as handling and storage of containers, clearing and forwarding to road, rail, and seaborne freight; ships agency; and marine fuels, lubricants, bunkers, and agricultural commodities. Further, the company invests in private and property equity portfolios; and engages in the private equity investment business. Additionally, it offers financial services comprising cash deposit management services; overdrafts, term loans and invoice discounting facilities, and mezzanine finance; retail banking products and services; and property lending services. Grindrod Limited was founded in 1910 and is based in Durban, South Africa.
Full GRDLY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.